Understanding how T cells attack skin cells in vitiligo
Autoreactive T Cell Function in Vitiligo
This study is looking at how certain immune cells called T cells behave in people with vitiligo, a condition that causes skin color loss, to better understand what happens in the body and find new ways to help treat it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10868481 on NIH RePORTER |
What this research studies
This research investigates the role of T cells in vitiligo, an autoimmune condition where the immune system mistakenly targets and destroys pigment-producing cells in the skin. By examining how these T cells function and migrate, the study aims to uncover the underlying mechanisms of this disease. Patients with vitiligo will be studied to correlate their skin changes with specific immune responses, providing insights into how autoimmunity develops and progresses. The research utilizes advanced techniques to analyze T cell behavior in affected skin, which may lead to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with vitiligo, particularly those experiencing significant skin changes.
Not a fit: Patients with vitiligo who are not actively experiencing skin changes or those with other unrelated autoimmune conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for vitiligo, helping to restore skin pigmentation and reduce the psychological impact of the disease.
How similar studies have performed: Previous research has shown promising results in understanding T cell behavior in other autoimmune diseases, suggesting that this approach may yield valuable insights for vitiligo as well.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Kent, Sally Choate — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Kent, Sally Choate
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.